Study period | Pre-screening | Screening | Baseline | Intervention (exergaming or usual care) | Intervention mid-point | Early discontinuation | Post-intervention | |
---|---|---|---|---|---|---|---|---|
Timepoint | Day -14 | Day -14 to day -7 | Week 0 | Weeks 1–12 | Week 6 | Discontinuation prior to week 12 | Weeks 13–14 | |
Assessment/procedure | Advertising of study | x | ||||||
Pre-screening risk assessment | x | |||||||
Inclusion and exclusion criteria | x | |||||||
Participant information sheet | x | |||||||
Informed consent form | x | |||||||
Adult Pre-Exercise Screening System (APSS) (stages 1 and 2) | x | |||||||
Assessment by medical officer of medical fitness to participate in physical activity | x | |||||||
Baseline interview (demographics; incarceration history; perceived health status; psychiatric history) | x | |||||||
Clinical assessment of cardiometabolic risk (APSS stage 3) • Body mass index (BMI) • Waist and hip circumference • Resting blood pressure • Lipid profile (total cholesterol, HDL, LDL, triglycerides) • Liver function • Blood glucose (HbA1c; fasting glucose) | x | x | x | |||||
Current Community Assessment of Psychic Experiences-Positive Scale (Current CAPE-P15) | x | x | ||||||
Depression Anxiety Stress Scale (DASS-21) | x | x | x | x | ||||
Simple Physical Activity Questionnaire (SIMPAQ) | x | x | x | x | ||||
OMNI-Walk/Run Scale of Perceived Exertion* | x | |||||||
YMCA Step Test (VO2max testing) | x | x | x | |||||
Dynamic Appraisal of Situational Aggression (DASA) | x | |||||||
Adverse event check | x | x | x | |||||
Compliance and adherence assessments | x | |||||||
Participant acceptability/perceived utility survey* | x | x | ||||||
Staff acceptability/feasibility survey* | x | x |